Association for Multiple Endocrine Neoplasia Disorders

AMEND wishes to support research and is providing up to £10,000 per year (subject to available funds) to enable medical researchers to supplement an existing project or pump-prime new research ideas.  The successful project must be specifically directed to the study of endocrine tumours within the context of multiple endocrine neoplasia. This award is currently only available to projects carried out within the United Kingdom and Eire.

Research Awards can only be made when AMEND has a surplus of funds.  Currently there are no surplus funds.  Please check back from time to time in case this should change.  Also follow us on Twitter to keep up to date with the status of our Research Awards.

For further information and criteria, please view the application form:  document AMEND Research Fund Application Form (55 KB)

 

AMEND is a National Institute for Health Research (NIHR) Non-Commercial Partner

Appropriate research studies funded through AMEND's Research Fund are now automatically eligible for NIHR Clinical Research Network (CRN) support and therefore entitled to:

  • Use of the NIHR Coordinated System for gaining NHS Permissions (NIHR CSP) which is accessed via the Integrated Research Application System (IRAS)
  • Access NHS support via the NIHR Clinical Research Network.

Please note that to be eligible for NIHR CRN support any research study we fund must also meet the standard study eligibility criteria, namely that it:

  • Requires NHS Research Ethics Committee approval and NHS permission
  • Is a discrete structured research project with an appropriate study protocol
  • Is of clear value to the NHS
  • Involves NHS patients, staff, premises, facilities or resources

Current and Past Award(s)